Hap Trading, LLC Lannett CO Inc Call Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$0.75 - $1.77 $15,525 - $36,639	-20,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.93 $15,444 - $29,007	9,900 Added 91.67%	20,700 $11,000
Q3 2021 Nov 10, 2021	BUY	$2.91 - $4.83 $31,428 - $52,164	10,800 New	10,800 $2,000
Q1 2021 May 14, 2021	SELL	$5.28 - $9.64 $124,608 - $227,504	-23,600 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.75 - $7.13 $30,475 - $37,789	5,300 Added 28.96%	23,600 $25,000

Q3 2020 Nov 13, 2020	BUY	$4.9 - $7.12 $9,800 - $14,240	2,000 Added 12.27%	18,300 $3,000
Q2 2020 Aug 10, 2020	SELL	$6.43 - $9.86 $49,511 - $75,922	-7,700 Reduced 32.08%	16,300 $3,000
Q1 2020 May 08, 2020	SELL	$6.36 - $10.05 $52,152 - $82,410	-8,200 Reduced 25.47%	24,000 $15,000
Q4 2019 Feb 11, 2020	BUY	$8.49 - $12.81 $67,920 - $102,480	8,000 Added 33.06%	32,200 $24,000
Q3 2019 Nov 12, 2019	BUY	$5.58 - $14.47 $135,036 - $350,174	24,200 New	24,200 $51,000
Q1 2019 May 10, 2019	SELL	$5.35 - $9.82 $57,779 - $106,056	-10,800 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$3.43 - $6.19 $37,044 - $66,852	10,800 New	10,800 $9,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.